Bill118th CongressFiled Jun 21, 2023Health
H.R. 4242
To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Jun 21, 2023)
This bill requires the Food and Drug Administration (FDA) to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy, including how to request support from the FDA for related investigational use exemptions.
What just happenedJun 23, 2023
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Crenshaw, Dan [R-TX-2](R-TX)Sponsor
2 cosponsors1 D1 R
2cosponsors1committees4actions6subjects
- Introduced in HouseJun 21, 2023
- Jun 23, 2023Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jun 21, 2023IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jun 21, 2023IntroReferralIntro-H
Introduced in House
- Jun 21, 2023IntroReferral1000
Introduced in House